secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001193125-22-256102
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD raises $7M via Series A Preferred from Rubric Capital, extends debt maturity to Oct 31
--------------------------------------------------------------------------------

- Issued 7,000 Series A Preferred shares to Rubric Capital Management for $7M gross proceeds; proceeds for working capital.
- Financing agreement maturity extended to Oct 31, 2022; further extension to Nov 30 possible with additional $7M equity raise.
- Issued warrants to Sixth Street lenders for 125,000 common shares at $0.01 exercise price, expiring Sep 30, 2032.
- Company continues strategic alternatives process to strengthen long-term financial position.
- Securities issued in private placement under Section 4(a)(2) and Regulation D; no registration rights granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/0001193125-22-256102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/d378570d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-256102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer